North China Pharmaceutical Co Ltd (600812) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, North China Pharmaceutical Co Ltd (600812) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥170.24 Million ≈ $24.91 Million USD) by net assets (CN¥6.67 Billion ≈ $976.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

North China Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)

This chart illustrates how North China Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 600812 liabilities breakdown for a breakdown of total debt and financial obligations.

North China Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of North China Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Couchbase Inc NASDAQ:BASE	-0.028x
IRSA Inversiones y Representaciones SA BA:IRSA	0.001x
Grupo Aeroméxico S.A.B. de C.V MX:AEROMEX	-0.311x
Cheil Worldwide KO:030000	0.000x
Equital TA:EQTL	0.038x
Guoguang Electric Co Ltd Chengdu SHG:688776	-0.018x
Beijing Sanyuan Foods Co Ltd SHG:600429	0.034x
Ladder Capital Corp Class A NYSE:LADR	0.031x

Annual Cash Flow Conversion Efficiency for North China Pharmaceutical Co Ltd (1998–2024)

The table below shows the annual cash flow conversion efficiency of North China Pharmaceutical Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see North China Pharmaceutical Co Ltd (600812) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥6.67 Billion ≈ $976.71 Million	CN¥1.23 Billion ≈ $179.92 Million	0.184x	+12.77%
2023-12-31	CN¥6.27 Billion ≈ $917.56 Million	CN¥1.02 Billion ≈ $149.88 Million	0.163x	+1.30%
2022-12-31	CN¥6.23 Billion ≈ $911.41 Million	CN¥1.00 Billion ≈ $146.97 Million	0.161x	+7.75%
2021-12-31	CN¥7.02 Billion ≈ $1.03 Billion	CN¥1.05 Billion ≈ $153.68 Million	0.150x	+40.40%
2020-12-31	CN¥7.06 Billion ≈ $1.03 Billion	CN¥752.15 Million ≈ $110.06 Million	0.107x	-18.20%
2019-12-31	CN¥5.62 Billion ≈ $822.98 Million	CN¥732.97 Million ≈ $107.26 Million	0.130x	-7.23%
2018-12-31	CN¥5.51 Billion ≈ $806.58 Million	CN¥774.33 Million ≈ $113.31 Million	0.140x	+158.25%
2017-12-31	CN¥5.28 Billion ≈ $772.71 Million	CN¥287.25 Million ≈ $42.03 Million	0.054x	+164.46%
2016-12-31	CN¥5.29 Billion ≈ $774.28 Million	CN¥-446.53 Million ≈ $-65.34 Million	-0.084x	-463.04%
2015-12-31	CN¥5.27 Billion ≈ $771.13 Million	CN¥122.50 Million ≈ $17.92 Million	0.023x	+34.66%
2014-12-31	CN¥5.25 Billion ≈ $767.70 Million	CN¥90.56 Million ≈ $13.25 Million	0.017x	+153.00%
2013-12-31	CN¥4.15 Billion ≈ $606.67 Million	CN¥-135.03 Million ≈ $-19.76 Million	-0.033x	-112.90%
2012-12-31	CN¥4.18 Billion ≈ $611.39 Million	CN¥-63.92 Million ≈ $-9.35 Million	-0.015x	-108.83%
2011-12-31	CN¥1.31 Billion ≈ $192.27 Million	CN¥227.60 Million ≈ $33.30 Million	0.173x	+134.21%
2010-12-31	CN¥1.18 Billion ≈ $172.92 Million	CN¥-598.35 Million ≈ $-87.56 Million	-0.506x	-144.62%
2009-12-31	CN¥890.92 Million ≈ $130.37 Million	CN¥1.01 Billion ≈ $147.96 Million	1.135x	+74.64%
2008-12-31	CN¥1.67 Billion ≈ $244.43 Million	CN¥1.09 Billion ≈ $158.85 Million	0.650x	+42.40%
2007-12-31	CN¥1.46 Billion ≈ $213.02 Million	CN¥664.37 Million ≈ $97.22 Million	0.456x	+6.25%
2006-12-31	CN¥1.39 Billion ≈ $203.42 Million	CN¥597.12 Million ≈ $87.38 Million	0.430x	+179.39%
2005-12-31	CN¥1.46 Billion ≈ $213.37 Million	CN¥224.17 Million ≈ $32.80 Million	0.154x	-14.81%
2004-12-31	CN¥1.72 Billion ≈ $251.66 Million	CN¥310.39 Million ≈ $45.42 Million	0.180x	-14.31%
2003-12-31	CN¥2.76 Billion ≈ $403.19 Million	CN¥580.32 Million ≈ $84.92 Million	0.211x	-23.91%
2002-12-31	CN¥2.67 Billion ≈ $390.38 Million	CN¥738.50 Million ≈ $108.07 Million	0.277x	+103.57%
2001-12-31	CN¥2.70 Billion ≈ $395.23 Million	CN¥367.28 Million ≈ $53.74 Million	0.136x	+175.41%
2000-12-31	CN¥2.70 Billion ≈ $395.61 Million	CN¥133.49 Million ≈ $19.53 Million	0.049x	+135.17%
1999-12-31	CN¥2.66 Billion ≈ $389.44 Million	CN¥-373.62 Million ≈ $-54.67 Million	-0.140x	+17.86%
1998-12-31	CN¥1.91 Billion ≈ $279.75 Million	CN¥-326.74 Million ≈ $-47.81 Million	-0.171x	--

About North China Pharmaceutical Co Ltd

SHG:600812 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.31 Billion

CN¥8.96 Billion CNY

Market Cap Rank

#7992 Global

#2011 in China

Share Price

CN¥5.22

Change (1 day)

+0.19%

52-Week Range

CN¥5.10 - CN¥7.01

All Time High

CN¥18.60